Watch full video on YouTube
Can this Shot Cure PTSD? ‘The God Shot’ & Stellate Ganglion Block w/ Dr Eugene Lipov | Mike Drop 218
By Mike Ritland
By Mike Ritland
By Mike Ritland
Watch full video on YouTube
30 Comments
Interesting update on Can this Shot Cure PTSD? ‘The God Shot’ & Stellate Ganglion Block w/ Dr Eugene Lipov | Mike Drop 218. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Interesting update on Can this Shot Cure PTSD? ‘The God Shot’ & Stellate Ganglion Block w/ Dr Eugene Lipov | Mike Drop 218. Curious how the grades will trend next quarter.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Interesting update on Can this Shot Cure PTSD? ‘The God Shot’ & Stellate Ganglion Block w/ Dr Eugene Lipov | Mike Drop 218. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.